Total
0
Shares
Bod Australia (ASX:BDA) - CEO, Jo Patterson - The Market Herald
CEO, Jo Patterson
Source: InvestorStream
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Bod Australia (BDA) has recorded its highest-ever month of medicinal cannabis sales, filling 1789 MediCabilis prescriptions in April
  • This marks an 11 per cent increase from the 1617 prescriptions in March and brings the total MediCabilis orders filled in FY21 to 9519
  • Of the orders filled in April, 64 per cent of the prescriptions were repeat orders
  • This growth is based on the ongoing engagement and strong relationships with prescribers, physicians and healthcare professionals
  • Bod is up a healthy 18.9 per cent on the market and shares are trading at 44 cents

Bod Australia (BDA) has recorded its highest-ever month of medicinal cannabis sales, filling 1789 MediCabilis prescriptions in April.

This marks an 11 per cent increase from the 1617 prescriptions in March and brings the total MediCabilis orders filled in FY21 to 9519.

Of the orders filled in April, 64 per cent of the prescriptions were repeat orders.

This growth is based on the ongoing engagement and strong relationships with prescribers, physicians and healthcare professionals.

Since prescriptions first began in 2019, 13,624 MediCabilis units have been sold.

"MediCabilis volumes continue to grow at a very pleasing rate and the recent prescription sales growth further highlight's Bod's ability to generate strong revenues across one of the company's two core operating divisions," CEO Jo Patterson commented.

"The company continues to maintain a solid segment of the total Australian market through Special Access Scheme Category B," she said.

"The company has a number of new products in the pipeline that will be launched imminently. We anticipate that the introduction of new products and scale up of operations across both business divisions will unlock considerable value for shareholders," she added.

Bod is up a healthy 18.9 per cent on the market and shares are trading at 44 cents at 1:50 pm AEST.

BDA by the numbers
More From The Market Herald
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald

" Creso Pharma (ASX:CPH) completes US dual listing

Creso Pharma (CPH) is officially dual listed, after completing its listing on the US OTCQB stock exchange.
The Market Herald Video

" US regulator approves expanded use of Avita Medical’s (ASX:AVH) RECELL System

The US regulator has approved the expanded use of Avita Medical’s (AVH) RECELL system in combination with meshed autographs to treat burns patients.
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac - The Market Herald

" Advanced Human Imaging (ASX:AHI) signs term sheet with Cubert

Advanced Human Imaging (AHI) has signed a binding term sheet with Toronto-based digital health provider Cubert Inc.
Microequities Asset Management (ASX:MAM) posts 140pc boost to half-yearly profit

" Patrys (ASX:PAB) receives $600k R&D tax incentive refund

Patrys (PAB), through its wholly owned Nucleus Therapeutics subsidiary, has received a research and development (R&D) tax incentive refund of $626,780 for the